Kudva G C, Chandy M, Raghupathy P, Dennison D, Srivastava A, Bhushan V, Singh R
Department of Haematology, Christian Medical College and Hospital, Tamil Nadu, India.
Indian J Cancer. 1994 Jun;31(2):78-85.
Thirty-eight children with acute lymphoblastic leukaemia were treated with the BFM regimen. Thirty-six (94.7%) achieved complete remission (CR). Twenty 58.8%) of 34 evaluable patients are in continuous complete remission (CCR) at a median follow-up of 33 (range 19-81) months. Long-term disease-free survival was better in the 2-9 years age group (83%) when compared to the 10-14 years group (43%) (P < .05).
38名急性淋巴细胞白血病患儿接受了BFM方案治疗。36名（94.7%）实现了完全缓解（CR）。34名可评估患者中的20名（58.8%）在中位随访33个月（范围19 - 81个月）时处于持续完全缓解（CCR）状态。2至9岁年龄组的长期无病生存率（83%）优于10至14岁年龄组（43%）（P < 0.05）。
